Tag Archives: $RXII

Thoughts, six months later

Whoa, what happened out in UC-Davis? Pepper spraying students protesting peacefully? Not right. OK, back to some fun. A half-year. Six-months. 184 days. More grey hairs. This has been a fun experiment. Once a week (or so), I jot down … Continue reading

Posted in Random, Research, Uncategorized, Update | Tagged , , , , , , , , , , , , , | Leave a comment

No respect for RNAi ($RXII)

RNAi must feel like Rodney Dangerfield – it gets no respect. Back in 1998, RNAi was hot. It was so hot that just 8 years later, Andrew Fire and Craig Mello, received the Nobel Prize in Physiology or Medicine for … Continue reading

Posted in How did that happen?, I don't get it, Why did they do that? | Tagged , , , , , , , , , , , , , , , , , , | 1 Comment

$CYTR: $INNO and out with chaperones

It has been an interesting couple of years for $CYTR. Their lead asset heading into 2008 was arimoclomol, a small molecule thought to activate Hsp70, which was placed on clinical hold (January 2008) over potential toxicology concerns in rats. While … Continue reading

Posted in Jewel in the rough? | Tagged , , , , , | 1 Comment

Sell in May, and go away?

While some investors might heed the “Sell in May, and go away” mantra, if you’re a little guy looking for ideas in biotech, going away in June is probably more realistic. Better for me, as it coincides with the end … Continue reading

Posted in Why did they do that? | Tagged , , , , | 1 Comment